The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94.EBI
Sloan-Kettering Institute For Cancer Research
Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series.EBI
Memorial Sloan-Kettering Cancer Center
Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90.EBI
Infinity Pharmaceuticals
Pan- and isoform-specific inhibition of Hsp90: Design strategy and recent advances.EBI
Shandong University
Design and synthesis of Grp94 selective inhibitors based on Phe199 induced fit mechanism and their anti-inflammatory effects.EBI
China Pharmaceutical University
The Development of Hsp90?-Selective Inhibitors to Overcome Detriments Associated with EBI
The University of Notre Dame
Discovery of a Potent Grp94 Selective Inhibitor with Anti-Inflammatory Efficacy in a Mouse Model of Ulcerative Colitis.EBI
China Pharmaceutical University
Resorcinol-Based Grp94-Selective Inhibitors.EBI
The University of Kansas
Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding.EBI
Hauptman-Woodward Medical Research Institute